CAR-T Cell Immunotherapy for Ovarian Cancer: Hushing the Silent Killer

Investigators outline the principles of CAR-T therapy and then highlight its limitations in the context of solid tumors. They focus on preclinical and clinical findings achieved in CAR-T-mediated targeting of different ovarian cancer-associated target antigens.